FDA Says Hospira Plant Continues To Have Quality Issues
The U.S. Food and Drug Administration has again found quality-control issues at a Hospira Inc. plant in North Carolina, the drugmaker said Tuesday, two years after the agency spotlighted defective equipment...To view the full article, register now.
Already a subscriber? Click here to view full article